CinCor Pharma, Inc. Contracts & Agreements
18 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (3)
- Human Resources (5)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Agreement and Plan of Merger, dated as of January 8, 2023, by and among CinCor Pharma, Inc., AstraZeneca Finance and Holdings Inc. and Cinnamon Acquisition, Inc (Filed With SEC on January 9, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on August 11, 2022)
- Form of Underwriting Agreement (Filed With SEC on August 8, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 8, 2022)
- Form of Underwriting Agreement (Filed With SEC on January 3, 2022)
- 2019 Stock Option Plan (Filed With SEC on January 3, 2022)
- 2022 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (Filed With SEC on January 3, 2022)
- 2022 Employee Stock Purchase Plan (Filed With SEC on January 3, 2022)
- Amended and Restated Executive Employment Agreement, dated as December 29, 2021, by and between the Registrant and Marc de Garidel (Filed With SEC on January 3, 2022)
- Amended and Restated Executive Employment Agreement, dated as December 30, 2021, by and between the Registrant and Mary Theresa Coelho (Filed With SEC on January 3, 2022)
- Amended and Restated Executive Employment Agreement, dated as December 29, 2021, by and between the Registrant and Mason Freeman (Filed With SEC on January 3, 2022)
- Amended and Restated Executive Employment Agreement, dated as December 29, 2021, by and between the Registrant and Catherine Pearce (Filed With SEC on January 3, 2022)
- Voting Agreement and Proxy, dated as December 22, 2021, by and between the Registrant and CinRx Pharma, LLC (Filed With SEC on December 23, 2021)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated September 22, 2021 (Filed With SEC on December 17, 2021)
- 2019 Stock Option Plan (Filed With SEC on December 17, 2021)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on December 17, 2021)
- License Agreement, dated as of May 13, 2019, by and among the Registrant, F. Hoffman-La Roche Ltd and Hoffmann-La Roche Inc (Filed With SEC on December 17, 2021)
- Amended and Restated Management Services Agreement, dated as of April 16, 2020, by and between the Registrant and CinRx Pharma, LLC (Filed With SEC on December 17, 2021)
